Lupin Soars on USFDA Nod for Billion-Dollar Drug     Exclusive 180-day window fuels stock jump after Tolvaptan approval for kidney disease treatment. Shares of the Mumbai-based pharmaceutical giant, Lupin Limited, experienced a significant surge, climbing nearly 3% on Thursday, … Continue reading Lupin Soars on USFDA Nod for Billion-Dollar Drug